Advanced Viral Research Corp. Hires Public Relations Firm
01 Jun 2007
YONKERS, N.Y.--(BUSINESS WIRE)--Advanced Viral Research Corporation (OTCBB: ADVR), a research based biopharmaceutical company dedicated to anti-cancer drug discovery and development, announced today it has appointed the life sciences marketing communications firm The Signature Agency to assist in its overall branding and investor communications.
Advanced Viral Research Corporation is developing a new class of cytoprotective drug which may be useful in the treatment of cachexia (body wasting), appetite loss, and lethargy in patients with cancer and HIV-AIDS. The compound also is being evaluated in a Phase II topical wound healing study after demonstrating accelerated wound healing properties in a well established animal model at the University of Miami.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.